Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy

Transactions of the American Ophthalmological Society

Volumn 98, Issue , 2000, Pages 285-303

  Asbell, P A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALACICLOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; EXCIMER LASER; FEMALE; HERPES SIMPLEX KERATITIS; KERATECTOMY; LASER SURGERY; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT VIRUS INFECTION; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TITRATION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; FEMALE; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; KERATITIS, HERPETIC; POSTOPERATIVE CARE; RABBITS; RECURRENCE; SIMPLEXVIRUS; VALINE; VIRUS ACTIVATION;

EID: 0034527468     PISSN: 00659533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (161)

1. Herpes simplex eye infections: Clinical manifestations, pathogenesis and management
2. Herpes simplex in a developing country: Natural history and treatment of epithelial ulcers in Tunisia
3. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982
4. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982
5. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982
6. The epidemiology of infection with the human herpes viruses in Navajo children
7. Seroepidemiology of infections due to members of the herpesvirus group
8. Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction
9. Herpes simplex keratitis
10. Recovery of herpes-simplex virus from human trigeminal ganglions
11. Isolation of latent herpes-simplex virus from the superior cervical and vagus ganglions of human beings
12. The recurrence of herpetic keratitis following idoxuridine therapy
13. Some aspects of the clinical use of trifluorothymidine in the treatment of herpetic ulceration of the cornea
14. Recurrent herpes simplex virus ocular infection: Epidemiological and clinical features
15. Prognosis indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration
16. Dendritic (herpetic) keratitis. I. Incidence, seasonal variations, recurrence rate, visual impairment, therapy
17. Reassessment of idoxuridine therapy of herpetic keratitis
18. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease
19. A randomized, placebo-controlled trial of oral acyclovir for the prevention of recurrent herpes simplex virus eye disease
20. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis
21. Preventive treatment of herpetic keratitis with acyclovir tablets
22. Long-term oral acyclovir therapy: Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts
23. Discussion
24. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir
25. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: A multicenter double-blind trial
26. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes
27. Acyclovir prevents reactivation of herpes simplex labialis in skiers
28. Oral acyclovir to suppress frequently recurrent herpes labialis: A double-blimd, placebo-controlled trial
29. Valtrex (valaciclovir)
30. Analysis of viral DNA in isolates from patients with recurrent herpetic keratitis
31. Pathogenic mechanisms of recurrent herpes simplex virus infections
32. Dendritic (herpetic) keratitis: I. Incidence, seasonal variations, recurrence rate, visual impairment therapy
33. Recurrent herpes simplex keratitis treated with hormone-induced amenorrhea
34. Recurrent herpes simplex: A psychiatric and laboratory study
35. An alternative therapy of herpes-simplex recurrence and a possible role for prostaglandins
36. Inhibitors of prostaglandins synthesis as in inhibitors of herpes simplex virus replication
37. Spontaneous reactivation of experimental herpes simplex keratitis in rabbits
38. Adrenergic induction of HSV-1 ocular shedding in rabbits
39. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: Electrode model
40. Herpes simplex virus disease: Anterior segment of the eye
41. Recurrent HSV-1 corneal epithelial lesions induced by cyclophosphamide and dexamethasone in latently infected rabbits
42. Recurrence phenotypes and establishment of latency, following rabbit keratitis produced by multiple herpes simplex virus strains
43. Activation of latent herpes simplex by trigeminal sensory-root section
44. Reactivation of herpes simplex virus after decompression of the trigeminal nerve root
45. Trigeminal neuralgia treated by the injection of glycerol in the trigeminal cistern
46. Herpesvirus infection of cornea allografts
47. Herpes simplex virus and persistent epithelial defects after penetrating keratoplasty
48. Herpes simplex dendritic keratitis after keratoplasty
49. Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used
50. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1
51. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model
52. Acute and recurrent infection with herpes simplex virus in the mouse. A model for studying latency and recurrent disease
53. Trauma to the skin causes recurrence of herpes simplex in the mouse
54. Recurrent herpes simplex in the mouse. Inflammation in the skin and activation of virus in the ganglia following peripheral stimulation
55. Activation of latent herpes simplex encephalitis by chemical means
56. Reactivation of herpetic keratitis by epinephrine in rabbits
57. Reactivation of latent herpes simplex virus infection by ultraviolet light. A human model
58. Ultraviolet-induced recurrent herpes simplex virus keratitis
59. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir
60. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice
61. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation
62. Effect of immunosuppression on recurrent herpes simplex in mice
63. Recurrent cutaneous herpes simplex in hairless mice
64. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment
65. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia
66. The effect of trigeminal nerve and ganglion manipulation on recurrences of ocular herpes simplex in rabbits
67. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia. Electrode model
68. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea
69. HSV-1 shedding by iontophoresis of 6-hydroxydopamine followed by topical epinephrine
70. Reactivation of murine latent HSV infection by epinephrine iontophoresis
71. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency
72. Herpes simplex keratitis: Role of viral infection versus immune response
73. Recurrence of herpetic keratitis in corneal grafts
74. Penetrating keratoplasty in herpetic keratitis
75. Penetrating keratoplasty for herpetic keratitis. Prognostic and therapeutic determinants
76. Penetrating kertoplasty for herpes simplex keratitis
77. Corneal transplantation for herpes simplex keratitis
78. Prognosis and management of cornea transplantation for herpetic keratitis
79. Penetrating keratoplasty for herpes simplex keratitis and keratoconus
80. Excimer laser surgery of the cornea
81. Excimer laser photorefractive keratectomy
82. Clinical use of the 193-nm excimer laser in the treatment of corneal scars
83. Photorefractive keratectomy for astigmatism
84. Recurrence of herpes simplex after excimer laser keratectomy
85. Electron microscopic findings in a cornea with recurrence of herpes simplex keratitis after excimer laser phototherapeutic keratectomy
86. Excimer laser and reactivation of herpes simplex keratitis
87. Phototherapeutic keratectomy in herpes simplex keratitis
88. Excimer laser phototherapeutic keratectomy
89. Photorefractive keratectomy: The sankara nethralaya experience
90. Reactivation of latent herpes simplex virus by excimer laser photokeratectomy
91. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model
92. The response of Langerhans cells in the cornea to herpetic keratitis
93. Light microscopic evaluation of rabbit corneal nerves: Comparison of the normal with dendritic herpetic keratitis
94. Strain specificity of clinical isolates of herpes simplex virus
95. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice
96. Quantification of herpes simplex virus in rabbit corneal epithelium
97. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea
98. HSV-1 shedding by iontophoresis of 6-hydroxydopamine followed by topical epinephrine
99. Propranolol suppresses reactivation of herpes virus
100. Cold stress-induced recurrences of herpetic keratitis in the squirrel monkey
101. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency
102. Pathogenesis and latency of HSV-1
103. Infections with herpes simplex virus
104. Herpes simplex keratitis: Role of viral infection versus immune response
105. Recurrent HSV-1 corneal epithelial lesions induced by timolol iontophoresis in latently infected rabbits
106. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model
107. Recurrent herpes simplex in rabbit and man
108. Optical properties of the skin and eyes
109. Effects of ultraviolet radiation on the eye
110. Recovery of herpes-simplex virus from human trigeminal ganglions
111. Herpes simplex virus. Molecular biology and the possibility of corneal latency
112. Detection of herpes virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification
113. Evidence for herpes simplex viral latency in the human cornea
114. Extraneuronal herpetic latency: Animal and human corneal studies
115. Dectection of herpes viral genomes in normal and diseased corneal epithelium
116. Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used
117. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1
118. Recurrent herpes simplex virus type 1 corneal epithelial lesions after radial keratotomy in the rabbit
119. An improved model of recurrent herpetic eye disease in mice
120. Nerve growth factor deprivation results in the reactivation of latent herpes simplex in vitro
121. Recovery of corneal innervation following photorefractive keratoablation
122. Real-time confocal microscopic observations on human corneal nerves and wound healing after excimer laser photorefractive keratectomy
123. In vivo confocal microscopic after photorefractive keratectomy in humans. A prospective study
124. Corneal sensation after cataract and refractive surgery
125. Corneal reinnervation after photorefractive keratectomy and laser in situ keratomileusis: An in vivo study with a confocal videomicroscope
126. Herpes keratitis after radial keratotomy
127. Herpetic corneal ulcer following radial keratotomy
128. Density and organization of free nerve endings in the corneal epithelium of the rabbit
129. Neural remodeling following experimental surgery of the rabbit cornea
130. Collateral sprouts are replaced by regenerating neurites in the wounded epithelium
131. Oral acyclovir and herpes labialis: A randomized, double-blind, placebo-controlled study
132. Prophylactic therapy with oral acyclovir for experimental ultraviolet light-induced herpes simplex labialis
133. Suppression of frequently recurring gential herpes: A placebo-controlled double-blind trial of oral acyclovir
134. Double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection
135. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection
136. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent gential herpes
137. Prophylactic acyclovir effectively reduces herpes simplex virus type I reactivation after exposure of latently infected mice to ultraviolet B
138. Oral antiviral drugs in experimental herpes simplex keratitis
139. Valacyclovir
140. Valacyclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections
141. Wound healing anomalies after excimer laser photorefractive keratectomy: Correlation of clinical outcomes, corneal topography, and confocal microscopy
142. A randomized, placebo-controlled comparison of oval valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections
143. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial
144. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomized, double-blind clinical trial
145. Valaciclovir for the suppression of recurrent gential herpes simplex virus infection: A large-scale dose range-finding study
146. Valaciclovir for the suppression of recurrent genital HSV infection: A placebo controlled study of once daily therapy
147. Aerosolization of infectious virus by excimer laser
148. Herpes simplex keratitis after LASIK
149. Recovery of corneal nerve morphology following laser in situ keratomileusis